• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌:非编码 RNA 和外泌体非编码 RNA。

Bladder cancer: non-coding RNAs and exosomal non-coding RNAs.

机构信息

Department of Urology, Hangzhou Mingzhou Hospital, Hangzhou, 311215, Zhe'jiang, China.

Department of the First Surgery, Zhejiang Provincial Corps Hospital of Chinese People's Armed Police Force, Hangzhou, 310051, Zhe'jiang, China.

出版信息

Funct Integr Genomics. 2024 Aug 31;24(5):147. doi: 10.1007/s10142-024-01433-9.

DOI:10.1007/s10142-024-01433-9
PMID:39217254
Abstract

Bladder cancer (BCa) is a highly prevalent type of cancer worldwide, and it is responsible for numerous deaths and cases of disease. Due to the diverse nature of this disease, it is necessary to conduct significant research that delves deeper into the molecular aspects, to potentially discover novel diagnostic and therapeutic approaches. Lately, there has been a significant increase in the focus on non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), due to their growing recognition for their involvement in the progression and manifestation of BCa. The interest in exosomes has greatly grown due to their potential for transporting a diverse array of active substances, including proteins, nucleic acids, carbohydrates, and lipids. The combination of these components differs based on the specific cell and its condition. Research indicates that using exosomes could have considerable advantages in identifying and forecasting BCa, offering a less invasive alternative. The distinctive arrangement of the lipid bilayer membrane found in exosomes is what makes them particularly effective for administering treatments aimed at managing cancer. In this review, we have tried to summarize different ncRNAs that are involved in BCa pathogenesis. Moreover, we highlighted the role of exosomal ncRNAs in BCa.

摘要

膀胱癌(BCa)是一种在全球范围内高发的癌症,它导致了大量的死亡和疾病病例。由于这种疾病的多样性,有必要进行深入的分子研究,以潜在地发现新的诊断和治疗方法。最近,由于非编码 RNA(ncRNAs),包括 microRNAs(miRNAs)、长非编码 RNA(lncRNAs)和环状 RNA(circRNAs)在 BCa 进展和表现中的作用越来越受到重视,因此对它们的研究也越来越多。由于外泌体能够运输多种活性物质,包括蛋白质、核酸、碳水化合物和脂质,因此它们的潜力引起了极大的关注。这些成分的组合根据特定的细胞及其状态而有所不同。研究表明,使用外泌体在识别和预测 BCa 方面具有相当大的优势,提供了一种侵入性更小的选择。外泌体中脂质双层膜的独特排列方式使它们特别适合用于管理癌症的治疗。在这篇综述中,我们试图总结了参与 BCa 发病机制的不同 ncRNAs。此外,我们还强调了外泌体 ncRNAs 在 BCa 中的作用。

相似文献

1
Bladder cancer: non-coding RNAs and exosomal non-coding RNAs.膀胱癌:非编码 RNA 和外泌体非编码 RNA。
Funct Integr Genomics. 2024 Aug 31;24(5):147. doi: 10.1007/s10142-024-01433-9.
2
Role of exosomal non‑coding RNAs in ovarian cancer (Review).外泌体非编码 RNA 在卵巢癌中的作用(综述)。
Int J Mol Med. 2024 Oct;54(4). doi: 10.3892/ijmm.2024.5411. Epub 2024 Aug 12.
3
Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer.非编码 RNA 在膀胱癌代谢和发病机制中的作用。
Hum Cell. 2023 Jul;36(4):1343-1372. doi: 10.1007/s13577-023-00915-5. Epub 2023 May 20.
4
Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.肿瘤细胞和肿瘤相关巨噬细胞来源的外泌体非编码 RNA 在肿瘤微环境中的作用。
Mol Ther. 2022 Oct 5;30(10):3133-3154. doi: 10.1016/j.ymthe.2022.01.046. Epub 2022 Apr 9.
5
Non-Coding RNA as Biomarkers and Their Role in the Pathogenesis of Gastric Cancer-A Narrative Review.非编码 RNA 作为生物标志物及其在胃癌发病机制中的作用——叙述性综述。
Int J Mol Sci. 2024 May 9;25(10):5144. doi: 10.3390/ijms25105144.
6
Non-coding RNAs and angiogenesis in cardiovascular diseases: a comprehensive review.非编码 RNA 与心血管疾病中的血管生成:全面综述。
Mol Cell Biochem. 2024 Nov;479(11):2921-2953. doi: 10.1007/s11010-023-04919-5. Epub 2024 Feb 2.
7
Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications.非编码 RNA 综述:从机制到治疗应用。
Biochem Pharmacol. 2024 Jun;224:116218. doi: 10.1016/j.bcp.2024.116218. Epub 2024 Apr 21.
8
Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.聚焦乳腺癌中的外泌体非编码 RNA:lncRNA/circRNA-miRNA-靶轴的计算分析。
Int J Mol Sci. 2022 Jul 28;23(15):8351. doi: 10.3390/ijms23158351.
9
Adipose exosomal noncoding RNAs: Roles and mechanisms in metabolic diseases.脂肪细胞外泌体非编码 RNA:在代谢性疾病中的作用和机制。
Obes Rev. 2024 Jun;25(6):e13740. doi: 10.1111/obr.13740. Epub 2024 Apr 4.
10
Clinical implications of exosome-derived noncoding RNAs in liver.外泌体来源的非编码RNA在肝脏中的临床意义
Lab Invest. 2022 May;102(5):464-473. doi: 10.1038/s41374-021-00723-1. Epub 2022 Jan 10.

引用本文的文献

1
Role of non-coding RNA-regulated ferroptosis in colorectal cancer.非编码RNA调控的铁死亡在结直肠癌中的作用
Cell Death Discov. 2025 Jul 8;11(1):315. doi: 10.1038/s41420-025-02606-6.

本文引用的文献

1
LncRNA HEIH/miR-4500/IGF2BP1/c-Myc Feedback Loop Accelerates Bladder Cancer Cell Growth and Stemness.长链非编码RNA HEIH/微小RNA-4500/胰岛素样生长因子2结合蛋白1/原癌基因c-Myc反馈环加速膀胱癌细胞生长和干性
Bladder Cancer. 2022 Sep 15;8(3):255-267. doi: 10.3233/BLC-211544. eCollection 2022.
2
circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and stabilizing p53 mRNA.环状KDM1A通过吸附miR-889-3p/CPEB3并稳定p53 mRNA来抑制膀胱癌进展。
iScience. 2024 Mar 29;27(4):109624. doi: 10.1016/j.isci.2024.109624. eCollection 2024 Apr 19.
3
Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs.
膀胱癌来源的外泌体 circRNA_0013936 通过上调脂肪酸转运蛋白 2 和下调 PMN-MDSC 中的受体相互作用蛋白激酶 3 促进抑制性免疫。
Mol Cancer. 2024 Mar 9;23(1):52. doi: 10.1186/s12943-024-01968-2.
4
Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment.尿液外泌体miR-17-5p通过抑制其靶基因ARID4B和调节免疫微环境促进膀胱癌侵袭。
Clin Genitourin Cancer. 2024 Apr;22(2):569-579.e1. doi: 10.1016/j.clgc.2024.01.012. Epub 2024 Jan 22.
5
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment.非肌层浸润性膀胱癌的诊断与治疗:美国泌尿外科学会/泌尿外科学会指南:2024年修订版
J Urol. 2024 Apr;211(4):533-538. doi: 10.1097/JU.0000000000003846. Epub 2024 Jan 24.
6
, a target of miR-299-5p, suppresses the progression of bladder cancer.FOXO1, a target of miR-299-5p, suppresses the progression of bladder cancer.
Aging (Albany NY). 2023 Dec 13;15(23):14306-14322. doi: 10.18632/aging.205304.
7
Tumor-derived exosomal miR-1247-3p promotes angiogenesis in bladder cancer by targeting FOXO1.肿瘤来源的外泌体 miR-1247-3p 通过靶向 FOXO1 促进膀胱癌血管生成。
Cancer Biol Ther. 2024 Dec 31;25(1):2290033. doi: 10.1080/15384047.2023.2290033. Epub 2023 Dec 10.
8
Exosomal Long Non-Coding Ribonucleic Acid Ribonuclease Component of Mitochondrial Ribonucleic Acid Processing Endoribonuclease Is Defined as a Potential Non-Invasive Diagnostic Biomarker for Bladder Cancer and Facilitates Tumorigenesis via the miR-206/G6PD Axis.线粒体核糖核酸加工内切核糖核酸酶的外泌体长链非编码核糖核酸核糖核酸酶成分被定义为膀胱癌的一种潜在非侵入性诊断生物标志物,并通过miR-206/G6PD轴促进肿瘤发生。
Cancers (Basel). 2023 Nov 6;15(21):5305. doi: 10.3390/cancers15215305.
9
MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity.微小 RNA-367-3p 直接靶向 RAB23,抑制膀胱癌细胞的增殖、迁移和侵袭,并增加顺铂敏感性。
J Cancer Res Clin Oncol. 2023 Dec;149(20):17807-17821. doi: 10.1007/s00432-023-05484-6. Epub 2023 Nov 8.
10
MiR-205-3p suppresses bladder cancer progression via GLO1 mediated P38/ERK activation.miR-205-3p 通过 GLO1 介导的 P38/ERK 激活抑制膀胱癌进展。
BMC Cancer. 2023 Oct 9;23(1):956. doi: 10.1186/s12885-023-11175-9.